BOFAS News & Events

This pages lists all the latest news and upcoming events.

 

To access 'Foot Print' (the BOFAS Bulletin) please click here (members only)

 

Latest News

News

BOFAS News

EFAS Lyon 2021 - Hybrid Annual Meeting

October 21-22-23 - Combined Face to Face and Virtual Meeting

The EFAS Congress Lyon 2021 will be the first hybrid congress from the European Foot and Ankle Society. 

EFAS hopes BOFAS members and others will join them in person for 3 amazing days of congress, to meet each other and exchange ideas, but in the current climate going abroad might still be difficult. EFAS would therefore like to extend the opportunity for all to be part of the congress by going HYBRID for the first time. 

12345678

 

BOFAS Hosted Events

BOFAS Principles Course - Dubai

The aim is to give Overseas Trainee Orthopaedic Surgeons a solid grounding in the principles and the decision making in Foot & Ankle Surgery.

There is an emphasis on clinical examination of cases, small group discussions and learning surgical approaches in the cadaver lab.

This is the first course BOFAS is running in UAE and the aim is to expand the Foot and Ankle education and training in the Middle East and Gulf area.

Venue - Le Meridien, Dubai, United Arab Emirates

Documents to download

BOFAS Principles Course Taunton

These courses are aimed at Higher Surgical Trainees / ST3 onwards and are designed to teach the core of Foot and Ankle surgery in an informal and interactive environment. The emphasis is on clinical examination cases, discussion groups and typical day-to-day clinic scenarios. Although not an exam preparation course, content is taught to the standard expected in the FRCS(Tr & Orth) exam; that of a day-one non-specialist orthopaedic consultant. Applications will open on 1st September 2023.

Venue - Taunton (TBC)

 

 

Documents to download


 

BOFAS Affiliated Courses

Other External Events / Courses

Togay Koç
/ Categories: Abstracts, 2023, Poster

Wasting everyone’s time – an observational study of current practice after injections

C. Flood, A. Carne, B. Singh, M. Solan

Introduction: Injections are offered to thousands of patients suffering with a range of musculoskeletal conditions every year. Most are cortisone injections. Each injection serves both a diagnostic and a therapeutic purpose. The initial response to injection (Local Anaesthetic) helps confirm the clinical diagnosis. The duration of pain relief (steroid) is unpredictable. These dual goals make planning follow-up appointments difficult. A delayed appointment might affect patient recall about the extent of initial benefit. At an early review, the benefits will usually still be apparent, precluding useful planning. As a prelude to improving efficiency, we sought to establish current practice in our region of the UK, and among the BOFAS membership.

Methods: An online questionnaire was administered to clinicians who treat patients with injections.

Results: 256 responses were included in the analysis. These included 138 foot & ankle surgeons and 119 other specialists. Foot & ankle surgeons mostly administer injections in theatre (40.5%) or the imaging department (35.7%). In other specialties outpatient department injections predominate (54%). This may reflect the diagnostic intent and anatomical complexity of injections in the foot and ankle setting. Routine follow-up appointments were given in >80% of cases for first injections and >50% of subsequent injections by all clinicians. Routine appointments are almost all at six to twelve weeks post-injection. This is the case for first and subsequent injections. At follow-up, the vast majority of injections were still working. Immediate pain relief and duration of effect are the most influential factors when planning further treatment.

Conclusion: This data shows that the traditional six to twelve week follow-up appointment after injection is inefficient, and therefore a waste of both clinician and patients’ time. Strategies to record pain scores and invite review only when the benefits of injection have faded have the potential to save millions pounds of healthcare costs.

Print
354